Laila C. Roisman - Concepedia

Author

Laila C. Roisman

Also Known As

L Roisman, L. Roisman, L.C. Roisman, Laila C Roisman, Laila C. Roisman, Laila Catalina Roisman, Laila Roisman, Laila C. Roisman

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Soroka Medical Center Ben-Gurion University of the Negev Rabin Medical Center Tel Aviv University Shaare Zedek Medical Center

About

Laila C. Roisman is an author at Soroka Medical Center specializing in medicine, radiation oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.7K
2	Cell Biology	4	4	355
3	Health Sciences	2	2	153
4	Biochemistry	2	2	786
5	Natural Sciences	1	1	83

Laila C. Roisman

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke Qing‐zhang Tuo, Peng Lei, K A Jackman, Molecular Psychiatry Ischemic StrokeBiochemistryMedicineLipid PeroxidationVascular Biology	2017	703
Interferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection Ka Yee Fung, Niamh E. Mangan, Helen Cumming, Science	2013	247
Inquiring into the Differential Action of Interferons (IFNs): an IFN-α2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-β Diego Adhemar Jaitin, Laila C. Roisman, Eva Jaks, Molecular and Cellular Biology	2006	223
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors Elizabeth Dudnik, Nir Peled, Hovav Nechushtan, Journal of Thoracic Oncology Tumor Mutational BurdenDeath Ligand 1MedicineImmunologyCancer Genomics	2018	219
New Structural and Functional Aspects of the Type I Interferon-Receptor Interaction Revealed by Comprehensive Mutational Analysis of the Binding Interface Jacob Piehler, Laila C. Roisman, Gideon Schreiber Journal of Biological Chemistry Viral ReplicationImmunologyMolecular BiologyViral Structural ProteinIfn Receptor	2000	151
A Molecular Basis for NKT Cell Recognition of CD1d-Self-Antigen Thierry Mallevaey, Andrew Clarke, James Scott‐Browne, Immunity ImmunologyAntigen ProcessingAutoimmunityNkt Cell RecognitionCellular Immune Response	2011	130
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data Elizabeth Dudnik, Mor Moskovitz, Sameh Daher, Lung Cancer Real-life DataMedicineCancer ManagementImmune Checkpoint InhibitorCancer Treatment	2017	101
Mutational Analysis of the IFNAR1 Binding Site on IFNα2 Reveals the Architecture of a Weak Ligand–Receptor Binding-site Laila C. Roisman, Diego Adhemar Jaitin, Darren P. Baker, Journal of Molecular Biology Ifnar1 Binding SiteSignal TransductionMutational AnalysisBiochemistryProtein Function	2005	83
Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking Laila C. Roisman, Jacob Piehler, Jean‐Yves Trosset, Proceedings of the National Academy of Sciences	2001	80
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi) Elizabeth Dudnik, Elias Bshara, Ahuva Grubstein, Lung Cancer MedicineImmunologyPathologyBronchial NeoplasmImmune Checkpoint Inhibitor	2018	74

Page 1